A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
Phase 3
Completed
- Conditions
- Cataract
- Interventions
- Device: MD-15 Intraocular Lens
- Registration Number
- NCT02888210
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
To evaluate safety and efficacy of MD-15 intraocular lens implanted into the aphakic eyes
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
- Patients who intend to undergo phacoemulsification cataract extraction
Exclusion Criteria
- Patients who undergo secondary implantation
- Patients with vision loss induced by causes other than cataract
- Patients who the principal investigator/subinvestigator considers ineligible for enrollment
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Arm && Interventions
Group Intervention Description MD-15 MD-15 Intraocular Lens Investigational intraocular lens
- Primary Outcome Measures
Name Time Method Corrected visual acuity Week 52
- Secondary Outcome Measures
Name Time Method